Syra Health Corp 8K

Syra Health Corp. announced its first profitable quarter in Q1 2026, supported by strong revenue growth, margin expansion, improved cash position, and key contract renewals and product advances, while reiterating confidence in achieving full-year profitability.

Syra Health Corp. reported its first-ever profitable quarter for Q1 2026, with net income of approximately $241,000 and EPS of $0.02, driven by 22% year-over-year revenue growth to $2.3 million, an 11-point expansion in gross margin to 42.7%, and disciplined cost reductions across all major operating expense categories. The company highlighted strong performance and mix shift in its higher-margin population health solutions, improved cash position to $2.9 million with no long-term debt, and a material swing in adjusted EBITDA to $244,495 from a prior-year loss. Management reaffirmed expectations for full-year 2026 profitability despite anticipated quarterly variability from milestone-based contracts, and noted several operational achievements including renewals of public health and behavioral health training contracts, expansion of services for a national managed care organization, enhancements to its Syrenity behavioral health platform, and industry recognition for its SyraBot chatbot and digital health innovation.

Filing Facts

CIK

1922335

Ticker

-

Form

8K

Source Type

sec

Accession

0001493152-26-021629

Alert Tier

7